Status:
UNKNOWN
Non-exposure Simple Suturing EFTR (NESS-EFTR) With Laparoscopic Sentinel Lymph Node Navigation for EGC (Senorita3-phase 2)
Lead Sponsor:
National Cancer Center, Korea
Conditions:
Early Gastric Cancer
Eligibility:
All Genders
20-80 years
Phase:
PHASE2
Brief Summary
Laparoscopic sentinel lymph node dissection and stomach preserving surgery in early gastric cancer is less invasive method which can increase quality of life. Current stomach preserving surgery after ...
Eligibility Criteria
Inclusion
- single lesion of adenocarcinoma in preoperative endoscopic biopsy
- clinical stage T1N0 in the preoperative evaluation of endoscopy and computed tomography
- tumor size: less than 3cm
- location: 3cm far from the pylorus or cardia
- aged 20 to 80
- ECOG 0 or 1
- patient who signed the agreement
- patient who is suspected to underwent laparoscopy assisted gastrectomy
Exclusion
- absolute indication of endoscopic submucosal resection
- inoperable due to poor cardiac, pulmonary function
- pregnant
- having allergic reaction, previous upper abdominal surgery except laparoscopic cholecystectomy, previous radiation therapy to upper abdomen
- diagnosed as malignancy within 5 years except carcinoma in situ of cervix cancer and thyroid cancer
Key Trial Info
Start Date :
September 12 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT03837301
Start Date
September 12 2018
End Date
December 1 2021
Last Update
February 12 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Center
Goyang, South Korea, 10408